Effective date 2024-12-20 Label type HUMAN PRESCRIPTION DRUG LABEL Version 9 Source full-release Hydrated at 2026-05-31 21:19:59 Key Label Information# Uses INDICATIONS AND USAGE Cyanocobalamin is indicated for vitamin B12 deficiencies due to malabsorption which may be associated with the following conditions: Addisonian (pernicious) anemia Gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy Fish tapeworm infestation Malignancy of pancreas or bowel Folic acid deficiency It may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see Drug Interactions ), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue
TAKE TIME OBSERVE LABEL DIRECTIONS
Safety in Context: Study Limitations While the clinical trial safety data for AOD-9604 is extensive and reassuring, understanding the limitations of this evidence base is essential for balanced interpretation
These injections are commonly used to support: Energy production Metabolism Fat breakdown Mental clarity Immune support Overall wellness Many people turn to vitamin injections when they feel fatigued, struggle with weight management, or want additional wellness support alongside healthy lifestyle changes
However, these changes were not significantly different between them
The subsequent increase in metabolic rate leads to a reduction in white adipose tissue and has been shown to produce significant weight loss in preclinical studies without affecting appetite
